Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/EQL stock hub

STO/EQL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/EQLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

905.1M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/EQL

In the news

Latest news · STO/EQL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E73

P25 n/aP50 n/aP75 n/a

ROE5.1

P25 n/aP50 n/aP75 n/a

ROIC5.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/EQL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

SEK

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	55
Employees Change	27%
Employees Change Percent	96.43
Enterprise value	SEK 1.3B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	SEK 905.1M
Price	SEK 30.65
Price currency	SEK
Rev Per Employee	7,866,563.64x
Sector	Healthcare
Sic	2834
Symbol	sto/EQL
Website	https://www.eqlpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.39%
EV Earnings	101.03x
EV/EBIT	26.02x
EV/EBITDA	18.11x
EV/FCF	55.27x
EV/Sales	2.93x
FCF yield	2.53%
Forward P/E	16.66x
P/B ratio	3.39x
P/E ratio	72.98x
P/S ratio	2.09x
PE Ratio10 Y	147.47x
PE Ratio3 Y	58.15x
PE Ratio5 Y	88.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.25%
EBITDA Margin	16.17%
FCF margin	5.3%
Gross margin	37.64%
Gross Profit	SEK 162.8M
Gross Profit Growth	4.42%
Gross Profit Growth Q	-26.92%
Gross Profit Growth3 Y	12.02%
Gross Profit Growth5 Y	26.13%
Net Income	SEK 12.5M
Net Income Growth	-70.93%
Net Income Growth3 Y	-25.98%
Net Income Growth5 Y	3.88%
Pretax Margin	4.21%
Profit Margin	2.9%
Profit Per Employee	SEK 227,964
ROA	3.67
Roa5y	7.57
ROCE	7.6
ROE	5.14
Roe5y	18.4
ROIC	5.31
Roic5y	14.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.63%
Cagr1y	-60.01%
Cagr3y	-3.77%
Cagr5y	-2.11%
EPS Growth	-70.83
EPS Growth3 Y	-26.08
EPS Growth5 Y	3.32
FCF Growth3 Y	-5.5%
FCF Growth5 Y	-17.41%
OCF Growth10 Y	28.37%
OCF Growth3 Y	0.89%
OCF Growth5 Y	-13.93%
Revenue Growth	15.84x
Revenue Growth Q	6.1x
Revenue Growth3 Y	18.51x
Revenue Growth5 Y	19.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.52
Assets	SEK 850.9M
Cash	SEK 86.8M
Current Assets	SEK 403.9M
Current Liabilities	SEK 210.2M
Debt	SEK 448.4M
Debt EBITDA	SEK 6.41
Debt Equity	SEK 1.68
Debt FCF	SEK 19.57
Equity	SEK 267.1M
Interest Coverage	1.6
Liabilities	SEK 583.8M
Long Term Assets	SEK 447M
Long Term Liabilities	SEK 373.6M
Net Cash	SEK -361.6M
Net Cash By Market Cap	SEK -39.96
Net Debt EBITDA	SEK 5.17
Net Debt Equity	SEK 1.35
Net Debt FCF	SEK 15.78
Tangible Book Value	SEK -174.1M
Tangible Book Value Per Share	SEK -5.89
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.92
Inventory Turnover	1.42
Net Working Capital	SEK 210.1M
Quick ratio	0.97
Working Capital	SEK 193.6M
Working Capital Turnover	SEK 2.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	407.01%
1Y total return	-59.99%
200-day SMA	63.12
3Y total return	-10.9%
50-day SMA	53.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-10.12%
All Time High	98.6
All Time High Change	-68.91%
All Time High Date	2025-07-28
All Time Low	2.8
All Time Low Change	994.64%
All Time Low Date	2015-02-18
ATR	4.29
Beta	0.37
Beta1y	1.14
Beta2y	0.76
Ch YTD	-46.97
High	36
High52	98.6
High52 Date	2025-07-28
High52ch	-68.91%
Low	30.3
Low52	30.3
Low52 Date	2026-05-08
Low52ch	1.16%
Ma50ch	-42.21%
Price vs 200-day SMA	-51.44%
RSI	23.83
RSI Monthly	32.63
RSI Weekly	26.33
Sharpe ratio	-1.25x
Sortino ratio	-1.37
Total Return	-0.92%
Tr YTD	-46.97
Tr1m	-43.03%
Tr1w	-35.88%
Tr3m	-50.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 48.7M
Operating Income Growth	-27.73
Operating Income Growth Q	-77.74
Operating Income Growth3 Y	5.6
Operating Income Growth5 Y	33.41
Operating margin	11.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,723,018%
Net Borrowing	9,756,000
Shares Insiders	2.38%
Shares Institutions	1.59%
Shares Out	29,529,610
Shares Qo Q	0.73%
Shares Yo Y	0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 22.9M
Average Volume	78,896.55x
Bv Per Share	9.04
CAPEX	SEK -5.4M
Ch10y	375.2
Ch1m	-43.03
Ch1w	-35.88
Ch1y	-59.99
Ch3m	-50.24
Ch3y	-10.9
Ch5y	-10.12
Ch6m	-42.71
Change	-42.39%
Change From Open	-9.32
Close	53.2
Days Gap	-36.47
Depreciation Amortization	21,273,328
Dollar Volume	35,284,494.6
Earnings Date	2026-05-08
EBIT	SEK 48.7M
EBITDA	SEK 70M
EPS	SEK 0.42
F Score	5
FCF	SEK 22.9M
FCF EV Yield	1.81x
FCF Per Share	SEK 0.78
Financing CF	43,237,000
Fiscal Year End	March
Founded	2,006
Graham Number	9.24459
Graham Upside	-69.84
Income Tax	SEK 5.7M
Investing CF	-67,241,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Lynch Fair Value	SEK 2.1
Lynch Upside	-93.15
Ma150	55.71
Ma150ch	-44.99%
Ma20	51.07
Ma20ch	-39.98%
Net CF	4,357,000
Open	33.8
P FCF Ratio	39.49
P OCF Ratio	31.91
Position In Range	6.14
Ppne	5,903,000
Price Date	2026-05-08
Price EBITDA	SEK 12.94
Relative Volume	14.59x
Revenue	432,661,000x
Tax By Revenue	1.31x
Tax Rate	31.13%
Tr6m	-42.71%
Volume	1,151,207

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/EQL pay a dividend?

Capital-return profile for this ticker.

Performance

STO/EQL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/EQL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.6%

Share of float held by funds and institutions

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

STO/EQL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

23.8

Below 30: short-term oversold

Price vs 200-day MA

-51.4%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

-1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/EQL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/EQL stock rating?

sto/EQL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/EQL analysis?

The full report lives at /stocks/sto/EQL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/EQL?

The latest report frames sto/EQL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/EQL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.